Charanjit Dhillon
Direttore/Membro del Consiglio presso OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC
Posizioni attive di Charanjit Dhillon
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC | Direttore/Membro del Consiglio | 23/04/2021 | - |
| Independent Dir/Board Member | 23/04/2021 | - | |
Oxford Cannabinoid Technologies Ltd.
 Oxford Cannabinoid Technologies Ltd. Pharmaceuticals: OtherHealth Technology Oxford Cannabinoid Technologies Ltd. engages in researching, developing and licensing cannabinoid-based compounds and therapies. Its therapies are used in medical applications, such as inflammatory diseases (arthritis, and auto-immune inflammatory and inflammatory eye diseases), oncology, neurological disorders (addiction, Alzheimer’s, depression, epilepsy, and Parkinson’s disease) and pain management. The company was founded in 2017 and is headquartered in Oxford, the United Kingdom. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Charanjit Dhillon
Precedenti posizioni note di Charanjit Dhillon
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Lorantis Ltd.
 Lorantis Ltd. Pharmaceuticals: MajorHealth Technology Lorantis Ltd. used to discover and develop drugs. The company had discovered a fundamental immune mechanism, by which the immune response to any disease-causing antigen may be suppressed. It used pursue immunology drug discovery and development programmes to address unmet medical needs. Lorantis was founded in 1998 and was headquartered in Cambridge, UK | Direttore Finanziario/CFO | - | 01/10/2005 |
Formazione di Charanjit Dhillon
| University of Hertfordshire | Masters Business Admin |
Statistiche
Distribuzione geografica
| Regno Unito | 5 |
Posizioni
| Director/Board Member | 2 |
| Director of Finance/CFO | 1 |
| Independent Dir/Board Member | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC | Health Technology |
| Aziende private | 2 |
|---|---|
Lorantis Ltd.
Lorantis Ltd. Pharmaceuticals: MajorHealth Technology Lorantis Ltd. used to discover and develop drugs. The company had discovered a fundamental immune mechanism, by which the immune response to any disease-causing antigen may be suppressed. It used pursue immunology drug discovery and development programmes to address unmet medical needs. Lorantis was founded in 1998 and was headquartered in Cambridge, UK | Health Technology |
Oxford Cannabinoid Technologies Ltd.
Oxford Cannabinoid Technologies Ltd. Pharmaceuticals: OtherHealth Technology Oxford Cannabinoid Technologies Ltd. engages in researching, developing and licensing cannabinoid-based compounds and therapies. Its therapies are used in medical applications, such as inflammatory diseases (arthritis, and auto-immune inflammatory and inflammatory eye diseases), oncology, neurological disorders (addiction, Alzheimer’s, depression, epilepsy, and Parkinson’s disease) and pain management. The company was founded in 2017 and is headquartered in Oxford, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Charanjit Dhillon
- Esperienza